Chairman's Address to Shareholders — 2017 Annual General Meeting

From Chairman Bob Proulx’s Address to Shareholders at the 2018 Annual General Meeting, held 31 May, 2018:

“We all know that far to many people’s lives are adversely affected by cancer and so our mission is clear — we have to develop a new, more sensitive way to detect and diagnose cancer.”

Read Chairman’s Address to Shareholders — 2017 Annual General Meeting